Listenly

What is the drug RasenQ and why is its FDA approval considered a breakthrough for pancreatic cancer?

Answered in Shein Limps to a B IPO & GTA 6 Extended Trailer Just Dropped · Morning Brew Daily

— questions searchable right now

What is the drug RasenQ and why is its FDA approval considered a breakthrough for pancreatic cancer?

RasenQ, developed by Revolution Medicines, is the first drug to successfully target the KRAS protein, which drives nearly all pancreatic cancers and was…

Neal Freyman on Morning Brew DailyAll answers from this podcast →
Full answer and detailsRead the whole answer, key facts and every other question from this episode

In short

RasenQ, developed by Revolution Medicines, is the first drug to successfully target the KRAS protein, which drives nearly all pancreatic cancers and was…

Neal Freyman · Shein Limps to a $27B IPO & GTA 6 Extended Trailer Just Dropped · Morning Brew Daily

Key takeaways

  • RasenQ, developed by Revolution Medicines, is the first drug to successfully target the KRAS protein, which drives nearly all pancreatic cancers and was…

The full answer

RasenQ, developed by Revolution Medicines, is the first drug to successfully target the KRAS protein, which drives nearly all pancreatic cancers and was…

More answers from this episode

 ·  All answers from Morning Brew Daily →
—
—
0:00
0:00